Reply to the regulatory inquiry letter on information disclosure of Sansure Biotech Inc.'s 2023 annual report from Zhongshen Zhonghuan Accounting Firm (special general partnership)

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.